Table 2.
Patient Demographics, Clinical Characteristics, and Utilization (N=2008)
| N | Mean (SD) or Percent | |
|---|---|---|
| Demographics | ||
| Patient Age | 2008 | 54.1 (9.3) |
| Male | 58 | |
| Clinical Characteristics | ||
| Systolic BP | 1965 | 126.3 (15.1) |
| A1c | 1916 | 7.3 (1.5) |
| LDL | 1825 | 97.5 (42.6) |
| BMI* | 969 | 34.4 (7.6) |
| ASPIRIN USE (%) | 2008 | 71% |
| Comorbidities | ||
| CHF (%) | 2008 | 23% |
| CVD (%) | 2008 | 9% |
| ASTHMA (%) | 2008 | 10% |
| COPD (%) | 2008 | 5% |
| HTN (%) | 2008 | 52% |
|
| ||
| Utilization (reported in HPRRVs) | ||
| Ambulatory Management Costs | 2008 | $3,116 ($2,399) |
| Potentially Avoidable Costs+ | 781 | $2,623 (4,763) |
| Total Costs
|
2008 | $4,137 ($4,211)
|
| Outpatient Pharmacy | ||
| Number of Glucose Scripts | 2008 | 11.3 (11.1) |
| % Generic** | 1529 | 60% (39%) |
| Number of Hypertension Scripts | 2008 | 10.2 (12.1) |
| % Generic** | 1323 | 80% (33%) |
| Number of Cholesterol Scripts | 2008 | 5.8 (6.91) |
| % Generic** | 1212 | 12% (27%) |
| Number of Other Scripts | 2008 | 18.98 (22.42) |
| % Generic** | 1687 | 47% (32%) |
**
Among those with at least one Script
BMI= Body mass index
+
Among 781 episodes with utilization